Celsius (NASDAQ:CELH) Downgraded to Hold Rating by Zacks Research

Key Points

• Zacks Research downgraded Celsius from a "strong-buy" rating to a "hold" rating, indicating a more cautious outlook for the stock.
• Celsius has received mostly positive ratings from analysts, with nineteen analysts rating it as a "buy" and a current consensus target price of $62.40.
• The company's recent earnings report showed a significant revenue increase, with $739.30 million for the quarter, surpassing analyst estimates.

Celsius (NASDAQ:CELH - Get Free Report) was downgraded by stock analysts at Zacks Research from a "strong-buy" rating to a "hold" rating in a research note issued on Monday,Zacks.com reports.

CELH has been the topic of several other research reports. Citigroup reiterated a "buy" rating on shares of Celsius in a research note on Sunday, August 31st. TD Cowen upgraded Celsius from a "hold" rating to a "buy" rating and lifted their target price for the company from $37.00 to $55.00 in a research note on Monday, June 16th. Morgan Stanley set a $70.00 price target on Celsius in a report on Tuesday, September 30th. Needham & Company LLC raised their price target on Celsius from $60.00 to $70.00 and gave the stock a "buy" rating in a report on Friday, September 5th. Finally, B. Riley raised their price target on Celsius from $56.00 to $75.00 and gave the stock a "buy" rating in a report on Tuesday, September 2nd. Nineteen research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Celsius currently has a consensus rating of "Moderate Buy" and a consensus target price of $62.40.

Celsius Stock Performance

Shares of Celsius stock opened at $61.06 on Monday. The stock's fifty day moving average is $55.86 and its two-hundred day moving average is $45.39. The company has a market capitalization of $15.75 billion, a PE ratio of 165.03, a price-to-earnings-growth ratio of 1.32 and a beta of 1.38. The company has a quick ratio of 1.76, a current ratio of 2.11 and a debt-to-equity ratio of 0.68. Celsius has a 52 week low of $21.10 and a 52 week high of $63.50.

Celsius (NASDAQ:CELH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The company had revenue of $739.30 million for the quarter, compared to analyst estimates of $632.13 million. During the same quarter in the previous year, the firm earned $0.28 earnings per share. The firm's quarterly revenue was up 83.9% compared to the same quarter last year. As a group, analysts expect that Celsius will post 0.89 earnings per share for the current year.

Insider Buying and Selling

In other Celsius news, CFO Jarrod Langhans sold 5,000 shares of the firm's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $60.00, for a total value of $300,000.00. Following the sale, the chief financial officer directly owned 104,227 shares of the company's stock, valued at approximately $6,253,620. This trade represents a 4.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Paul H. Storey sold 7,500 shares of the firm's stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $60.93, for a total value of $456,975.00. Following the completion of the sale, the insider directly owned 37,550 shares in the company, valued at approximately $2,287,921.50. The trade was a 16.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 560,667 shares of company stock valued at $27,240,162 in the last 90 days. Corporate insiders own 2.20% of the company's stock.

Institutional Trading of Celsius

Institutional investors have recently made changes to their positions in the company. Westside Investment Management Inc. acquired a new stake in shares of Celsius in the first quarter worth approximately $32,000. Summit Securities Group LLC acquired a new stake in Celsius in the 1st quarter valued at about $34,000. Hantz Financial Services Inc. raised its holdings in Celsius by 1,476.0% in the 2nd quarter. Hantz Financial Services Inc. now owns 788 shares of the company's stock valued at $37,000 after acquiring an additional 738 shares during the last quarter. UMB Bank n.a. raised its holdings in Celsius by 145.0% in the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock valued at $51,000 after acquiring an additional 844 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in Celsius by 244.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the company's stock valued at $52,000 after buying an additional 794 shares in the last quarter. 60.95% of the stock is owned by institutional investors and hedge funds.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.